Spondyloarthritis (SpA) is characterised by inflammation in the axial skeleton (sacroiliitis, spondylitis), peripheral joints, and entheses. Extraskeletal manifestations can occur such as anterior uveitis, psoriasis, and inflammatory bowel disease. HLA-B27 is the major genetic risk factor.
The entire group of SpA has a global prevalence of 0.1% to 1.9%, with variations between countries and ethnicities. AS is the largest subgroup. The association with HLA-B27 ranges from ~50% to 95%. In the general population HLA-B27 is present in 8-10% of Caucasians. .About 5% of patients with chronic low back pain have a spondyloarthritis.
Previously SpA was viewed as consisting of interrelated subgroups that included ankylosing spondylitis (AS), reactive arthritis, or undifferentiated spondyloarthritis. The current thinking distinguishes between predominant axial SpA and predominant peripheral SpA.
Validated classification criteria exist for both axial and peripheral SpA. Sacroiliitis on MRI is an important radiological finding in classification.
The term spondyloarthritis is preferred over spondyloarthropathy due to the inflammatory nature of the condition.
Sometimes the term seronegative spondyloarthritis is used which means that the patient is negative for rheumatoid factor and anti-CCP. Unlike Rheumatoid Arthritis, the distribution of the affected peripheral joints is asymmetrical, with the large joints of the lower limbs being predominantly affected in peripheral spondyloarthritis.
Inflammatory Back Pain
The age of onset is typically under 40. They have stiffness that is worse with rest and improved with exercise. The "back" pain is typically in the buttock, and has an insidious onset. Mornings are usually the worst, and they may wake up in the second half of the night. Response to NSAIDs is the rule.
Examination findings include an abnormal Shober test, and extraarticular manifestations such as psoriasis, uveitis, and inflammatory bowel disease.
Features that aren't suggestive of inflammatory back pain are older age (>40 years), diffuse ache, abrupt onset, history of trauma, radicular symptoms, weight loss, night sweats, fever, history of cancer, worsening with exercise and in the evenings, and generalised aching. NSAID response may be moderate at best.
|Calin criteria||Berlin criteria||ASAS criteria|
|(at least four of five present)||(at least two of four present)||(at least four of five present)|
Axial spondyloarthritis is a spectrum that runs from nonradiographic axial SpA (nr-axSpA) to ankylosing spondylitis. All patients with AS start as nr-axSpA, but not all patients with nr-axSpA progress to AS.
|>1 Clinical criteria PLUS Radiographic criteria|
|Radiographic sacroiliitis >Grade 2 bilaterally or >Grade 3-4 unilaterally|
|In patients with back pain ≥ 3 months and age at onset < 45 years|
|Sacroiliitis on imaging*
|SpA features†:||Sacroiliitis on imaging*:|
|*Sensitivity 82.9%, specificity 84.4%; n = 649 patients with chronic back pain and age at onset <45 years. Imaging arm (sacroiliitis) alone has a sensitivity of 66.2% and a specificity of 97.3%.|
†Elevated CRP is considered an SpA feature in the context of chronic back pain.
|Arthritis* or enthesitis or dactylitis|
|Plus ≥ 1 of||or||Plus ≥ 2 of the remaining:|
|*Peripheral arthritis: usually predominantly lower limb and/or asymmetric arthritis.
IBP: inflammatory back pain.
There is a predilection for the axial skeleton and entheses. Sacroiliitis is the cardinal sign. HLA-B27 confers a genetic risk. Clinical manifestations are inflammatory low back pain, stiffness, and a late finding of limitation of spinal range of motion.
Extraarticular manifestations are acute anterior uveitis, psoriasis, and inflammatory bowel disease.
Peripheral features include asymmetrical, oligoarticular, lower limb predominant arthritis +/- enthesitis (e.g. plantar fasciitis, insertional Achilles tendonitis). This is compared to small joint symmetrical arthritis in Rheumatoid Arthritis.
The assessment includes
- Disease activity: BASDAI and bloods
- Structure: X-ray/MRI and DEXA
- Function: BASFI
- Movement: BASMI
Plain film radiographic features are more typical of later stage disease, however MRI can detect early disease.
Radiologic features of ankylosing spondylitis include
- Sacroiliac joint: erosions, ankylosis, juxtaarticular osteopenia, ossification of the ligamentous attachment to the ischial tuberosity or iliac crest or the greater trochanter
- Spine: erosions at vertebral corners (shiny corners), squaring of the vertebral bodies (Romanus lesion), syndesmophytes, ossification of the annulus fibrosus and longitudinal ligament, erosions of the discovertebral junction, calcification of the intervertebral discs, pseudoarthrosis, and bone oedema especially if juxaarticular
MRI is the gold standard for assessment of inflammatory changes in the SIJ and spine.
Definitions of what constitutes a positive MRI of the SIJ and spine have been published by ASAS.
|Tissue||Inflammatory Changes||Structural Changes|
|Bone marrow||Sacroiliitis (bone marrow edema or
osteitis) in one or both parts of
the SI joint (sacral or iliac)
Bone bridges or ankylosis
|Bone marrow edema related to SpA
is located periarticularly
|Synovium||Synovitis: depicted only by T1/
Gd-DTPA sequences; STIR
sequences cannot differentiate
between synovitis and physiologic
joint fluid; synovitis is a rare lesion
|Bone bridges or ankylosis|
|Joint capsule||Capsulitis: comparable to synovitis;
both anterior and posterior joint
capsule can be affected
|Bone bridges or ankylosis|
|Ligaments||Enthesitis: seen in the junction of
ligaments and tendons to the bone
|Degeneration of ligament|
|Tissue||Inflammatory Changes||Structural Changes|
|Vertebral body||Inflammation (spondylitis) in the bone marrow, mainly in the corners||New bone formation
eventually erosions or destruction of
the vertebral body (e.g., fracture)
|Ossification of the disc|
|Inflammation with or
of the vertebral body
|New bone formation and ankylosis in
|Ligaments||Enthesitis, mainly of
the supraspinal and
|Degeneration of ligaments|
Early diagnosis is essential for good outcomes, the average delay in diagnosis is 9 years. Obstacles that cause a delay are patient behaviour, chronic low back pain being extremely common, poor awareness, reliance on plain films in early disease, non- or misuse of HLA-B27.
Physiotherapy plays a role in restoring and maintaining posture and movement. Home exercises must be continued for life. Exercise is critical at all stages and the patient should be referred early.
Medical management for both axial and peripheral spondyloarthritis includes NSAIDs, anti-TNFα drugs (adalimumab, etanercept, infliximab), and more recently IL-17 inhibitors.
The response to NSAIDs is almost 80% in AS vs ~15% in mechanical back pain, and they may reduce radiographic progression with continuous use.
For peripheral but not axial spondyloarthritis sulfasalazine and methotrexate may play a role as DMARDs, but not for axial disease. Local corticosteroid injections can be useful in oligoarticular forms of arthritis.
- Ehrenfeld. Spondyloarthropathies. Best practice & research. Clinical rheumatology 2012. 26:135-45. PMID: 22424199. DOI.
- Dougados & Baeten. Spondyloarthritis. Lancet (London, England) 2011. 377:2127-37. PMID: 21684383. DOI.
- Taurog et al.. Ankylosing Spondylitis and Axial Spondyloarthritis. The New England journal of medicine 2016. 374:2563-74. PMID: 27355535. DOI.
- Sieper. Developments in therapies for spondyloarthritis. Nature reviews. Rheumatology 2012. 8:280-7. PMID: 22487798. DOI.
- Braun et al.. 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Annals of the rheumatic diseases 2011. 70:896-904. PMID: 21540199. DOI. Full Text.